Gem Aromatics Limited Fully Utilizes IPO Proceeds by Q4FY26

gem aromatics has successfully completed the utilization of its Initial Public Offer (IPO) proceeds as of the quarter ended March 31, 2026. The company submitted the final monitoring agency report to the stock exchanges, confirming that the gross proceeds of Rs 1,750.00 million have been fully deployed. The report, issued by CRISIL Ratings Limited, was prepared in compliance with Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Issue Details and Allocation

The IPO, which opened for subscription from August 19, 2025, to August 21, 2025, comprised equity shares with a total issue size of Rs 1,750.00 million. After deducting issue expenses amounting to Rs 121.37 million, the net proceeds available for deployment were Rs 1,628.63 million. The company allocated these funds towards specific objectives, including the repayment of borrowings and general corporate purposes.

Particulars Amount (Rs. million) Gross proceeds 1,750.00 Less: Issue Expenses 121.37 Net Proceeds 1,628.63

Utilization of Proceeds

The primary object of the issue was the prepayment or repayment of outstanding borrowings availed by the company and its subsidiary, Krystal Ingredients Private Limited. A total of Rs 1,400.00 million was utilized for this purpose. Additionally, funds were allocated to general corporate purposes and issue expenses. The actual issue expenses were lower than estimated, resulting in a saving of Rs 4.58 million, which was subsequently added to the general corporate purposes allocation.

Sr. No. Item Head Revised Amount (Rs in million) Amount Utilized (Rs in million) 1 Prepayment of borrowings 1,400.00 1,400.00 2 General Corporate Purposes 233.21 233.21 3 Issue expenses 116.79 116.79 - Total 1,750.00 1,750.00

Monitoring Agency Observations

CRISIL Ratings Limited, acting as the monitoring agency, confirmed that there were no deviations from the objects stated in the offer document. The agency verified the utilization based on a management undertaking, statutory auditor certificates, and bank statements. The report highlighted that the amount utilized for general corporate purposes did not exceed 25% of the gross proceeds. As of March 31, 2026, the IPO public issue account and monitoring account balances were nil, indicating the complete deployment of funds.

The board of directors approved the utilization of funds for general corporate purposes towards meeting expenses incurred in the ordinary course of business, including vendor payments for raw materials. With the full utilization of proceeds, this monitoring agency report serves as the final submission regarding the IPO fund deployment for Gem Aromatics Limited.

Gem Aromatics Limited has submitted its quarterly compliance certificate to the stock exchanges for the quarter and year ended March 31, 2026. The filing fulfills the company's regulatory obligations under SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Filing

The company filed the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 with both BSE Limited and National Stock Exchange of India Limited on April 04, 2026. Company Secretary and Compliance Officer Akshita Deepak Gohil signed and submitted the compliance documentation to the respective listing departments.

Parameter: Details Filing Date: April 04, 2026 Certificate Date: April 03, 2026 Reporting Period: Quarter and year ended March 31, 2026 Regulation: SEBI Regulation 74(5)

Certificate Confirmation

KFin Technologies Limited, serving as the company's Registrar and Share Transfer Agent, issued the confirmation certificate dated April 03, 2026. The certificate confirms that no Demat/Remat requests were processed during the quarter ended March 2026. Vice President Dnyanesh Gharote signed the certificate on behalf of KFin Technologies Limited.

Stock Exchange Details

The compliance filing was submitted to both major Indian stock exchanges where Gem Aromatics Limited shares are listed:

Exchange: Details BSE Limited: Scrip Code 544491 National Stock Exchange: Symbol GEMAROMA Filing Authority: Listing/Compliance Departments

Company Information

Gem Aromatics Limited, formerly known as Gem Aromatics Pvt. Ltd., operates as a manufacturer and exporter of essential oils and aromatic chemicals. The company maintains its registered office at A/410-411, A-Wing, Kailash Ind. Complex, Powai Vikhroli link Rd, Vikhroli West, Mumbai-400079, Maharashtra. The regulatory filing demonstrates the company's commitment to maintaining compliance with SEBI regulations and transparency requirements for listed entities.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.